4
Changes in Ownership
Celldex Therapeutics, Inc. Filed Acc 0001415889-22-008895
SVP, CHIEF MEDICAL OFFICER sold 19,000 shares at $37.30 ($708,715)
- SVP, CHIEF MEDICAL OFFICER acquired 64,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Young Diane C. SVP, CHIEF MEDICAL OFFICER | 2022-08-17 | Option exercise | +19,000 | $10.38 | $197,220 | 21,115 | D |
| Young Diane C. SVP, CHIEF MEDICAL OFFICER | 2022-08-17 | Sale | −19,000 | $37.30 | $708,715 | 2,115 | D |
| Young Diane C. SVP, CHIEF MEDICAL OFFICER | 2022-08-17 | Option exercise | +45,000 | $2.71 | $121,950 | 47,115 | D |
| Derivatives | |||||||
| Young Diane C. SVP, CHIEF MEDICAL OFFICER | 2022-08-17 | Option exercise · Incentive Stock Option | −19,000 | 48,400 | D | ||
| Young Diane C. SVP, CHIEF MEDICAL OFFICER | 2022-08-17 | Option exercise · Incentive Stock Option | −45,000 | 15,000 | D | ||
| Open-market sales · 19,000 sh · avg $37.30 · $708,715 | |||||||
Loading xslF345X03/form4-08192022_010835.xml…